EDGAR Filing Documents for 0001144204-12-037566

Form 8-K - Current report:

SEC Accession No. 0001144204-12-037566

Filing Date

2012-07-02

Accepted

2012-07-02 09:23:17

Documents

Period of Report

2012-06-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	v317506_8k.htm	8-K	53377
2	EXHIBIT 3.1	v317506_ex3-1.htm	EX-3.1	13399
3	EXHIBIT 3.2	v317506_ex3-2.htm	EX-3.2	9086
4	EXHIBIT 3.3	v317506_ex3-3.htm	EX-3.3	81662
5	EXHIBIT 4.1	v317506_ex4-1.htm	EX-4.1	24542
6	EXHIBIT 10.1	v317506_ex10-1.htm	EX-10.1	51410
7	EXHIBIT 10.2	v317506_ex10-2.htm	EX-10.2	167380
8	EXHIBIT 10.3	v317506_ex10-3.htm	EX-10.3	45066
9	EXHIBIT 10.4	v317506_ex10-4.htm	EX-10.4	10875
10	EXHIBIT 10.5	v317506_ex10-5.htm	EX-10.5	28516
	Complete submission text file	0001144204-12-037566.txt		486819

Mailing Address 135 BEAVER ST WATHAM MA 02452

Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700

INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)